Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndromes 15 spanning a wide spectrum of diseases, from simple steatosis to the more complex nonalcoholic steatohepatitis. To identify the deregulation that occurs in metabolic processes at the molecular level that give rise to these various NAFLD phenotypes, algorithms such as pathway enrichment analysis (PEA) can be used. These analyses
require the use of predefined pathway maps, which are composed of reactions 20 describing metabolic processes/subsystems. Unfortunately, the annotation of the metabolic subsystems can differ depending on the pathway database used, making these approaches subject to biases associated with different pathway annotations, and these methods cannot capture the balancing of cofactors and byproducts through the complex nature and interactions of genome-scale metabolic networks (GEMs). Here, 25
we introduce a framework entitled Minimum Network Enrichment Analysis (MiNEA) that is applied to GEMs to generate all possible alternative minimal networks (MiNs), which are possible and feasible networks composed of all the reactions pertaining to various metabolic subsystems that can synthesize a target metabolite. We applied MiNEA to investigate deregulated MiNs and to identify key 30 regulators in different NAFLD phenotypes, such as a fatty liver and liver inflammation, in both humans and mice by integrating condition-specific transcriptomics data from liver samples. We identified key deregulations in the synthesis of cholesteryl esters, cholesterol, and hexadecanoate in both humans and mice, and we found that key regulators of the hydrogen peroxide synthesis network 35
were regulated differently in humans and mice. We further identified which MiNs demonstrate the general and specific characteristics of the different NAFLD phenotypes. MiNEA is applicable to any GEM and to any desired target metabolite, making MiNEA flexible enough to study condition-specific metabolism for any given disease or organism. 40
Introduction
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in western countries [1] , affecting an estimated 25% to 45% of the general US population, though this percentage is much higher among individuals suffering from obesity and diabetes [1, 2] . There are two categories of NAFLD: steatosis, which is an 65 accumulation of fat in the liver, and nonalcoholic steatohepatitis (NASH), which consists of the additional presence of liver inflammation and hepatocellular injury with or without fibrosis [2] .
Gene deregulation occurs when the cell no longer maintains precise control over certain genes, and therefore expressed proteins, and is associated with various 70 diseases such as NAFLD. Determining which genes are deregulated in disease and how these genes are deregulated can increase the understanding of any disease as well as provide new pathways for therapeutic treatments. To study gene deregulation, pathway enrichment analysis (PEA) uses maps of metabolic processes and subsystem reactions to determine if a given list of genes (gene set) is associated with a certain 75 biochemical pathway, shedding important conceptual insight into gene deregulation.
Many PEA algorithms, such as ConsensusPathDB [3] and Piano [3, 4] , have been developed to identify biological processes based on gene sets, while other algorithms, such as IMPaLA [5] , are based on both gene and metabolite sets. While these algorithms can successfully provide insights about various disease phenotypes, they 80 use predefined metabolic maps that are limited to our current knowledge of these hugely intricate pathways and can differ depending on the pathway database used, meaning they could miss information about the wide range of complex metabolic interactions. These approaches are also subject to biases associated with the different pathway annotations, and they cannot capture the balancing of cofactors and 85 byproducts through the complex nature and interactions of genome-scale metabolic networks (GEMs).
To overcome this, a method has been developed based on elementary flux modes (EFMs), which are non-decomposable flux distributions in metabolic networks [6] .These flux distributions indicate a conceptual description of metabolic pathways. 90
This method computes EFMs from a given GEM and uses tissue-specific transcriptomics to identify a subset of tissue-specific EFMs. However, the enumeration of all EFMs in a GEM can be computationally intractable, and EFMs are not necessarily specific to a target metabolite synthesis, meaning that targeted pathways are not always able to elucidated using EFMs. 95
One could also use graph-based methods (GBM) that require network topologies and gene expression profiles as inputs to extract deregulated subnetworks that occur between two conditions [7-9]. These methods have been applied to protein-protein networks for prostate cancer study, and they are potentially applicable to metabolic networks. GBM methods use graph-theoretic properties on network topologies but 100 miss information about additional constraints, such as mass balance [10] and thermodynamics [11] . Ideally, the results for these studies would include a set of mass balanced subnetworks that could be used to understand the carbon, energy, and redox flows from precursor metabolites to target metabolites and complex metabolic tasks.
Here, we propose a method called Minimal Network Enrichment Analysis 105 (MiNEA) that compares two conditions using transcriptomics, proteomics, and metabolomics to identify deregulated minimal networks (MiNs), which are reactions pertaining to various metabolic subsystems that can synthesize a target metabolite. The MiNEA algorithm works by formulating metabolic tasks (MTs) to mimic the various NAFLD phenotypes, such as lipid droplet formation, 110 lipoapoptosis, liver inflammation, and oxidative stress. These MTs include the known set of metabolites necessary to form the modeled phenotype. The cell can use different pathways to form the same metabolites and create the same phenotypes, and the purpose of MiNEA is to identify deregulated alternative routes for a given MT between two conditions, such as a control and treatment. 115
First, MiNEA uses these MTs to compute alternative thermodynamically feasible MiNs applying thermodynamic constraints [11, 12] to a mouse GEM [13] . Then, it uses mouse and human liver sample expression data [1, 14] and identifies deregulated metabolic processes in mice and humans that potentially lead to the NAFLD phenotypes. 120
MiNEA identified an upregulation in the oxidative stress synthesis network in mice, but this network was found to be downregulated in humans. The cholesterol and triacylglycerol synthesis networks were deregulated in humans only, while the ceramide synthesis network was only deregulated in mice. We found downregulated reactions in the synthesis network for cholesteryl esters, cholesterol, and alanine in 125 both humans and mice. We further identified downregulated reactions in the superoxide anion (SOA) synthesis network in humans, specifically in NASH as opposed to steatosis, while upregulation was found in the SOA synthesis network in mice. This perturbation through the SOA synthesis network in NASH suggested an unbalanced ceramide synthesis, and studies have shown that the ceramide is a key 130 regulator of apoptosis and promotes fibrosis in the hepatic steatosis model [15, 16] .
MiNEA can generate MiNs for any target metabolite, e.g. a metabolite produced under specific phenotypes or a biomass building block [17] that is needed for cell growth. Additionally, MiNEA can integrate condition-and context-specific omics data to understand the deregulated phenotypes associated with a set of differentially 135 expressed genes. These characteristics make MiNEA a versatile tool for exploring and understanding different metabolic phenotypes.
Results and Discussions

Experimental details for MiNEA
Nonalcoholic fatty liver disease (NAFLD) has been defined as a metabolic disease 140 associated with insulin-resistance syndrome [18] . To study the differences seen in NAFLD phenotypes between mouse and human manifestations, we collected human expression data from the three diagnosis groups, normal (N), steatosis (S), and nonalcoholic steatohepatitis (NS), and mouse expression data from control and DDCsupplemented diet conditions for three genetically different mouse strains, AJ, B6, 145 and PWD. DDC-supplemented diet reproduces steatosis and NASH phenotypes (see Materials and Methods for detail). We refer to these data as human expression data and mouse expression data throughout this section and integrate it into a mouse model iMM1415 that is constructed based on a human GEM Recon1 [13] . We analyzed both human and mouse MTs using iMM1415 with the assumption that both types of 150 mammalian cells have a similar metabolism (See S1 text). In the following sections, we analyzed the deregulation of minimal networks in core reactions and enriched minimal networks based on the deregulation (up-or downregulated) genes.
Minimal networks 155
GEMs represent an entire cellular metabolic network in the form of mathematical constraints [19] . These network reconstructions have grown rapidly in the last decades, and now many GEMs for different organisms are available [20] . GEMs and condition-specific experimental data can be employed to generate and test hypotheses using the Minimal Network Enrichment analysis (MiNEA) framework that has been 160 developed in this study. As compared to a method the had been proposed for finding subnetworks from a GEM that optimizes only some part of metabolic networks to find subnetworks [21] , MiNEA optimizes whole metabolic networks to find minimal networks.
To examine the data that can be derived from MiNEA in terms of NAFLD, we first 165 wanted to compute MiNs for each of the MTs in Table MiNs. The percentage of HFRs was between 62% to 91% across the MTs (Table 1 ).
In the superoxide anion (SOA) and the hydrogen peroxide (H 2 O 2 ) synthesis, 62% and 89% of the reactions were HFRs, respectively, which suggests that the alternative MiNs for a SOA synthesis were more divergent compared to a H 2 O 2 synthesis. 
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As an expanded example, a MiN from the H 2 O 2 synthesis comprises many reactions from various metabolic subsystems ( Fig. 1) . Each MiN represents a group of active reactions, which are reactions that carries fluxes, within multiple metabolic subsystems/pathways that are required for a MT, while a pathway is a group of 200 annotated reactions. In the example in Figure 1 We further analyzed the HFRs within each phenotype and found that the most represented metabolic pathway in the apoptosis and inflammation (AI) phenotype was 215 related to amino acid metabolism (# phenotypic HFRs=36; Table 1 ; Fig. 2 ).
Interestingly, while the lipid droplet (LD) phenotype has many associated MTs, it shares 27 reactions in which 5 reactions are from the glycolysis/gluconeogenesis pathway ( Fig. 2) . These shared reactions can be constitutive candidates for the LD phenotypes. The HFRs forming the subsystems in Figure 2 are potential candidates 220 for the key regulators of the NAFLD phenotypes. 
Deregulation in HFRs
The HFRs within each MT create a topology of reaction hubs in metabolic networks that can be similar to protein hubs in protein-protein interaction networks [22, 23] , and the misregulation of these hubs in disease can explain the origin of disease 230 phenotypes. Therefore, we performed an analysis of HFR deregulation to study the NAFLD-specific phenotypes. We identified the up-and downregulated reactions from mouse and human expression data (described in S1) and analyzed the HFRs for which the associated genes were found to be deregulated. In humans, the number of downregulated HFRs was higher compared to upregulated HFRs for the NS vs N and 235
NS vs S across all phenotypes ( Table 2 ). In mice, however, the NS vs N, NS vs S, and S vs N comparisons showed a higher number of upregulated HFRs compared to downregulated ones for the oxidative stress (OS) phenotype, but for the LD and AI phenotypes, we observed similar patterns of up-and downregulated HFRs to humans (Table 2) . 240 
250
We further analyzed the deregulation in reaction hubs for each MT to identify the most perturbed MTs in NS and S and the differences between NS and S. In humans, the percentage of downregulated HFRs was higher than upregulated ones for the synthesis of all metabolites in the NS vs N and NS vs S states, while the percentage of upregulated HFRs was higher than downregulated ones for the S vs N state ( Fig. 3) . 255
There was a higher percentage of downregulated HFRs for the cholesterol (CHOL) and cholesteryl ester (CHOL_ES) synthesis networks in NS vs S and for the superoxide anion (SOA) and H 2 O 2 synthesis networks in NS vs S (Fig. 3 ). This means that downregulated HFRs have a higher impact on NASH phenotypes. OS"
Since the mouse strains AJ and PWD show phenotype specific to NS and S, respectively, and the mouse strain B6 show low S and NS phenotypes after feeding with the DDC diet (Materials and Methods) and thus we analyzed B6 separately. For mice, in NS vs N (the comparison associated to AJ) and B6 DDC vs N comparisons, we found that the percentage of downregulated HFRs in the SOA and H 2 O 2 synthesis 265 networks was higher than for upregulated ones (Fig. 3 ). This indicates synthesis networks of oxidative stress were found to be perturbed for AJ and B6 mice.
Additionally, for the NS vs S in mice, an elevated percentage of upregulated HFRs was identified for the synthesis of the triacylglycerol (TAG), phosphatidylinositol (PAIL), diacylglycerol (DAG), and phosphatidic acid (PA) metabolites, and a high 270 percentage of downregulated HFRs was found for the alanine (ALA) and glutamine (GLU) synthesis networks ( Fig. 3 ). This is consistent with the observation of lipid droplet perturbation in NASH and steatosis [24] , and it further suggests that the synthesis of TAG, PAIL, DAG, and PA are important for lipid droplet formation. Table 3 for the association of mouse strains to the symbols N, NS, and S. "B6 up" and "B6 down" represent the up-and downregulated HFRs for the B6 mouse strain comparing the 280 DDC vs control diet. We quantified the percentage of up-and downregulated HFR using a colored heat map.
Metabolites
Comparisons
% of deregulated HFRs
For the synthesis of ROS, such as H 2 O 2 , the human NS vs N case presented with a high percentage of downregulated HFRs, while the same case in mice presented with 285 a high percentage of upregulated HFRs (Fig. 3) . The reactions of the PPP associated with genes TKT1, TKT2, GND, and TALA were identified as downregulated HFRs in the NS vs N human. However, for the NS vs N mouse and B6 DDC vs N these reactions were identified as upregulated. PPP is known as a source of nicotinamide adenine dinucleotide phosphate (NADPH) that prevents oxidative stress. Thus, the 290 different patterns of regulation observed for these reactions can unbalance both NADPH concentration and H 2 O 2 synthesis. Interestingly it has been reported that the unbalance in NADPH production through PPP by either an under or over-production of NADPH may induce oxidative stress [25, 26] .
295
The acetyl CoA C acetyltransferase (ACACT1rm) and phosphoglycerate mutase reactions of the ceramide synthesis networks were identified as downregulated HFRs for the NS vs S and NS vs N in humans along with the NS vs N in mice. Thus, perturbation in the genes associated with these reactions can affect the ceramide level in NASH in both mice and humans. In line with this finding, a study suggested that 300 deregulated ceramide production promotes liver injury and the development of NASH through disruption of endoplasmic calcium homeostasis, as well as through the inhibition of autophagy [27] .
Enriched MTs in human and mouse based on deregulated genes 305
We want to identify deregulation at network level based on an enrichment analysis with deregulated enzymes or genes. A Minimal network (MiN) of a metabolic task Network Enrichment Analysis (MiNEA) (see Materials and Methods section) using mouse and human expression data. We identified deregulated genes (S1 text; Table S1-S3), and for each set of deregulated genes, we estimated the p value.
Applying MiNEA to the NS vs N human case, we identified deregulated MiNs which 315 corresponded to the synthesis of H 2 O 2 , PA, and TAG ( Table   3 ), suggesting that the deregulation of H 2 O 2 metabolism and oxidative stress contributes to NASH. Indeed, a study has shown that a marked alteration of H 2 O 2 concentration can lead to different types of oxidative stress [25] . When we applied MiNEA to NS vs S in humans, we found the most deregulated MiNs to be associated with CHOL synthesis (AMiNF = 0.7). Interestingly, TAG synthesis was also deregulated in NS vs N, suggesting that lipid droplet formation can be perturbed in the NASH state but through different components. 335
325
In mice, we did not observe marked deregulation in NS vs N and S vs N, but we observed significant deregulation in NS vs S for the synthesis of ALA, GLU, ceramide (CRM), PS, and phosphatidylethanolamine (PE) ( Table 3 ), suggesting that these MTs are subject to different perturbations between the NASH and steatosis 340 states.
In humans, MiNEA identified deregulation in the CHOL and TAG synthesis network, which are lipid droplet constituents. Similar deregulation was observed for the lipid droplet constituents in mice through the PS and PE synthesis networks. Thus, because 345 N" NS" S" MT"
Mouse! Human! Human!
Mouse!
MiNEA was applied with information on deregulated genes, we find that in both humans and mice, lipid droplet formation is perturbed but through different lipid constituents.
Enriched MTs in humans and mice based on up--and downregulated reactions 350
To identify whether a specific up-or downregulated MiN was associated with the NAFLD phenotypes, we performed MiNEA while enriching for up-and downregulated reactions separately (S1 Text).
In humans, we identified upregulated MiNs for the synthesis of PS and PE in N vs S 355 (Table 4 ; Table S6 & S7). For the NS vs N and NS vs S cases, we identified downregulated MiNs associated with the synthesis of CHOL_ES, CHOL, ALA, and GLU ( Table 5 ; Table S8 & S9), but none were found to be upregulated. This implies that in NASH the synthesis of cholesterol and the glucogenic amino acids alanine and glutamine are downregulated. Interestingly, in the NS vs N case, only 3% of the 360 cholesterol synthesis alternatives were significantly downregulated ( Table 5 ).
Although it is a relatively small frequency, it can provide important leads, such as deregulation in metabolic tasks and hypotheses that would have been missed by the commonly used pathway enrichment methods, such as [3, 5] . In general, these studies suggested that MiNEA can identify deregulated alternative MiNs under different 365 conditions. For example, previous pathway analysis methods [3, 5] lack an enumeration of alternatives that would have been failed to identify cholesterol synthesis as downregulated in NS vs N ( Table 5 ). In mice, the MiNs associated with the synthesis of ALA, CRM, PE, PS, CHOL_ES, 375 and GLU were identified as downregulated in NS vs N ( Table 5 ). Interestingly, in S vs N, only the GLU synthesis network was upregulated ( Table 4 ). For the NS vs S case, we found major deregulations. Specifically, we found five upregulated networks (PA, TAG, DAG, PAIL, and PS) and five downregulated (ALA, GLU, CRM, PS, and PE) synthesis networks. Within the alternative MiNs that are used for the synthesis of PS, 380
we found some networks that were upregulated and some that were downregulated.
Since there was a higher frequency of downregulated MiNs (AMiNF = 0.5) compared to upregulated ones (AMiNF = 0.167), we could hypothesize that the downregulation of PS synthesis is an important molecular mechanism specific to NASH. Here, if we use pathways enrichment methods [3, 5] then we cannot associate two different 385
AMiNF score for a given MT due to the lack of alternative enumeration and would have been failed to give a higher confidence to downregulation of PS synthesis. The cholesterol, glutamine, and alanine syntheses were found to be similarly deregulated in humans and mice for the NS vs N case. In contrast, the PS synthesis 395 was differently deregulated between the two species (Table 4 and there are available metabolic profiles for the N, NS, and B6 cases [1]. We integrated these profiles into the iMM1415 [11, 13] and found that, in this case, there are not marked changes in the MiNs and the result in the HFRs, which means we did not found a marked impact on the synthesis networks of NAFLD phenotypes. A further sensitivity analysis can guide future metabolomics studies to target metabolites that 410 have a marked thermodynamic impact on a metabolic network [28] . Thus, the information content of such metabolite sets can be influential and more relevant to the phenotypes under study.
We applied MiNEA for the study of deregulated metabolic processes rather signaling 415 and regulatory processed because metabolism is better characterized, as is shown with the increased availability of GEMS for many organisms. Despite the challenges in reconstructing constraint-based signaling networks, recently such reconstructions have started to become available. Signaling networks for the toll-like receptor (TLR) and epidermal growth factor receptor (EGFR) are now available, and MiNEA can be 420 extended to include these networks [29, 30] , meaning that MiNEA could easily be applied to the study of deregulation in signaling networks.
Materials and Methods 425
Microarray gene expression analysis of human liver samples
The microarray gene expression data pertaining to the three diagnostic groups (normal The B6 mouse strain showed less induction of the NASH phenotype than the AJ strain 
Association of mouse strains with human diagnoses groups 445
The normal (N) feeding group is associated with mice fed the control diet. All mice strains, AJ, B6 and PWD, were fed this diet and are labeled as N≈AJ, N≈PWD or N≈B6 to indicate the control diet and mouse strain. After feeding the DDCsupplemented diet, AJ and PWD showed high NASH phenotypes and high steatosis phenotypes, respectively [1] . Thus, under the DDC-supplemented diet, the symbol 450 for steatosis (S) is associated with the PWD mouse strain and the symbol for NASH (NS) is associated the AJ mouse strain (with DDC-supplemented diet: NS≈AJ, S≈PWD). Thus, NS vs N represents the AJ mouse strain treated with the DDC diet vs the AJ mouse strain fed the control diet, S vs N represents the PWD mouse strain treated with the DDC diet vs the PWD mouse strain fed the control diet, and NS vs S 455 represents the AJ mouse strain treated with the DDC diet vs the PWD mouse strain fed the DDC diet.
Metabolite concentration and RNA--seq gene expression data from mouse liver samples 460
Metabolite concentration data and RNA-seq gene expression data from mouse liver samples of the three mouse strains (AJ, B6, and PWD) measured under the control and DDC-supplemented diet conditions were collected from the work of Pandey et al.
[1]. The R-package "edgeR" [32] was used to identify the differentially expressed genes (DEGs) using three biological replicates of each mouse strain for both the 465 control and the DDC-treated conditions. Strain-wise identification of the DEGs between the DDC-treated and control states was performed separately for each mouse strain. We used the Benjamini-Hochberg procedure implemented in edgeR to control the false discovery rate to a level of 0.05 [31] . 470
Formulation of metabolic tasks (MTs) based on steatosis and steatohepatitis (NASH) phenotypes
Steatosis can occur due to the accumulation of lipid droplets in the liver, which can subsequently lead to NASH upon liver inflammation [33] . Lipid droplets are composed of many lipid metabolites [34, 35] , which are summarized in Table 7 . 475
Reactive oxygen species (ROS), such as the superoxide anion, can also damage hepatic membranes and play an important role in the development of NASH [36]. To study these various phenotypes and their role in the various forms of liver disease, the metabolites associated with their various phenotypes were examined. Table 7 summarizes the key metabolites associated with the major liver disease phenotypes: 480 lipid droplets, liver inflammation, apoptosis, and oxidative stress. We investigate the synthesis networks of these metabolites using MiNEA, where we called the synthesis of a metabolite as a metabolic task (MT). 
Minimal network enrichment analysis (MiNEA) algorithm
The cell can use various different pathways depending on the current state and 490 conditions of the environment to fulfill its immediate metabolic needs. In order for MiNEA to identify deregulated alternative routes for a given MT between two conditions (Fig. 4) , the inputs required are a metabolic model, a list of MTs, and gene or protein expression data. In this work, we used a mouse GEM (iMM1415) reconstructed by Sigurdsson and colleagues [13], a list of MTs which are the synthesis 495 of the metabolites shown in Table 7 , and gene expression data of mouse and human liver samples [1, 14] .
The MiNEA calculations begin by applying thermodynamic constraints to the model as described previously [11] to eliminate thermodynamically infeasible reactions, 500 meaning that reactions from the metabolic network can carry fluxes only if thermodynamics allows [12] (Fig. 4; step 1 ). Then, it enumerates all the thermodynamically feasible minimal-size networks (MiNs) that are active for the given list of provided MTs (Fig. 4; step 2) , and all of these MiNs are composed of reactions that carry non-zero flux. For this step, the following mixed-integer linear 505 programming (MILP) problem is applied with the objective of minimizing the number of reactions that carry flux or maximizing the number of reactions that cannot carry flux, while enforcing that the network should be able to synthesize the metabolites listed in Table 1 :
R GEM is the number of reactions in a GEM and !"#,! is a binary variable associated 510 with reaction i. Reversible reactions were split into two forward reactions. !",!"# is the maximum yield to produce a metabolite associated with a MT. The parameter c is generates MiNs that allow for flexibility on the yield from the MT. We chose c = 0.8 to allow for a yield of at least 80% of the maximum yield for the associated MT.
515
All alternative MiNs that are the minimum size (msize) for the synthesis of the metabolites in Table 1 are enumerated as described by Figueiredo and colleagues [40] ( Fig. 4; step 3 ). One can enumerate many alternative networks larger than msize, such as msize+1 and msize+2. Each MiN is a subnetwork comprising a set of reactions, metabolites, and reaction-associated genes through gene-protein-reaction (GPR) 520 association. In step 4, the deregulated genes and proteins that differ between the two conditions under study are identified (Fig. 4) . Finally, a hypergeometric test is performed on the sets of deregulated genes or deregulated reactions to identify the deregulated MiNs ( Fig. 4; Step 5).
525
Apply mass balance and thermodynamic constraints Minimize number of reactions Find alternative minimal networks (MiNs) that comprises active reactions Identified deregulated genes, proteins, reactions, and metabolites between two conditions
Hypergeometric test
Deregulated metabolic tasks and their alternative minimal networks (MiNs) Deregulated high frequency reactions
Step 1
Step 2
Step 3
Step 4
Step 5 
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Minimal network significance based on gene set and reaction set (Step 5)
The significance of the MiN based on the deregulated genes was calculated using the hypergeometric probability density function (P),
where k and K are the numbers of deregulated genes and the number of total genes in 540 a given MiN, respectively, and n and N are the total number of deregulated genes and the total number of genes of a metabolic network, respectively. In this context, the term "deregulated genes" is used for both up-or downregulated genes. To consider a MiN as upregulated, we need to ensure that the pair (T up , T down ) in the 575
MiN of T reactions cannot arise by chance in the context of the whole network. To obtain a better upregulation by chance, the p value was computed using equation (3) .
Note that an equal or better outcome than the pair (T up , T down ) satisfies two conditions:
(i) the number of downregulated reactions is smaller than or equal to T down , and (ii) the number of upregulated reactions is greater than or equal to T up , whereas the 580 number of reactions in the MiN remains unchanged.
We can compute the p value for downregulated reactions the same way as for the 585 upregulated reaction simply by changing up with down and down with up in the above equation.
Deregulated percentage (DRP)
We calculated the deregulated percentage (DRP) for each MiN, which indicates the 590 
Alternative minimal network frequency (AMiNF)
To extend the degree of confidence of the results from MiNEA, we introduced the alternative minimal network frequency (AMiNF) metric that determines the significantly deregulated percentage of MiNs for a given MT. If all the alternative 600
MiNs for a MT are significantly deregulated, AMiNF takes the value 1. The AMiNF is 0 when none of the MiNs for a MT are significantly deregulated.
MiNEA implementation
MiNEA was implemented using Matlab r2016a (The Mathworks, Natick, MA, USA), 605 and MILP problems were solved using CPLEX solver (ILOG, Sunnyvale, CA, USA).
The MILP gaps for all problems were converged to less than 0.05% in less than 2,400 s. We also plan to make the MiNEA algorithm available as a tool for distribution to the community.
Conclusions
In contrast to graph-based methods (GBM) and pathway enrichment analysis (PEA), the methodology introduced here (MiNEA) expands the notion of pathway into in a set of mass balanced subnetworks that can be used to understand the carbon, energy, and redox flows from precursor metabolites to target metabolites and complex 615 metabolic tasks. One of the main advantages of MiNEA compared to PEA is that MiNEA attempts an enumeration of alternative minimal networks for each metabolic task (MT), which helps us understand and study the MT flexibility. Although a large number of alternative enumerations for a complex metabolic network can be timeconsuming, once the enumeration is completed, MiNEA applies a statistical analysis 620 that is fast and extracts additional information, such as pertaining to the deregulation of MTs or the deregulation in reaction hubs. As an example of the power of MiNEA, we identified deregulation in key metabolic network of the ceramide and hydrogen peroxide synthesis, of NASH in both humans and mice. We also identified similar deregulation in NASH for the cholesterol synthesis networks in humans and mice, and 625 we found opposite deregulation for the phosphatidylserine synthesis network between humans and mice. MiNEA is highly applicable for the study of context-or conditionspecific metabolism because using this one can identify synthesis networks for any given target metabolite and further can employ condition-specific transcriptomics, proteomics, and metabolomics data. 630 635   Table S1 . Differentially expressed genes for human and mouse expression data. Table S2 . Upregulated reactions for human and mouse data. Table S3 . Downregulated reactions for human and mouse data. found that the mammalian organism with the highest number of genes homologous to Recon 1 genes was the mouse (Mus musculus) (1,415 genes, 97%). We compared iMM1415 and Recon1 and found that the iMM1415 shares 98% of reactions with Recon1 and in the reaming 2 % reactions more than 1.5 % reactions were associated to the extracellular transport mechanism. This suggests that Recon1 and iMM1415 685 have very similar metabolism.
Supplementary Tables
Identification and analysis of deregulated genes and reactions in human and mouse liver samples 690
To understand the nonalcoholic fatty liver disease (NAFLD) and the difference of the disease in mouse and human we collected human expression data form the three diagnosis groups: normal (N), steatosis (S), and nonalcoholic steatohepatitis (NS), and mouse expression data form the control and DDC-supplement diet conditions for the 695 three mouse strains: AJ, B6 and PWD (Materials and Methods). These data were referred as human expression data and mouse expression data throughout this section.
Differential expressed genes in human liver samples 700
To understand the NAFLD physiology we analyzed the differentially expressed genes (DEGs) in the human expression data. Out of the 1415 metabolic genes in iMM1415
[13], we identified 29, 484 and 363 DEGs in S vs N, NS vs S, and NS vs N, respectively (Fig. S1 upper panel and Table S1 ). Only 29 DEGs between S vs N may explain that the metabolic state was very similar between normal and steatosis. The 705 total number of DEGs between NS vs N and NS vs S were much higher than S vs N, and thus suggest a more pronounced alteration of the metabolic state of nonalcoholic steatohepatitis compared to steatosis and normal. Furthermore, the number of downregulated genes is greater than the number of upregulated genes in exclusively NS vs N and NS vs S (Fig. S1 ), suggesting that, in human NASH, the perturbation 710 leading to the metabolic state that characterizes it, is reached by downregulated genes.
Differential expressed genes in mouse liver samples
We analyzed the mouse expression data for DEGs as described in the material and methods section. Out of the 1415 metabolic genes in iMM1415, the total number of 715
DEGs between control and DDC-supplemented diet was similar across all strains with 247, 248 and 221 for AJ, B6 and PWD, respectively ( Fig. S2 lower panel) . Here, AJ and PWD are associated with NS vs N and S vs N, respectively (see materials and methods). Many up-and down-regulated genes were strain-specific. The number of up-and down-regulated strain-specific gene pairs for AJ, B6, and PWD were (48, 20), 720 (33, 29), and (39, 62), respectively (Fig. S1 lower panel and Table S1 ). The number of up-regulated genes was greater than the number of down-regulated genes for the AJ strain, while for the PWD strain the opposite was true. Numbers of up-and downregulated genes were very similar for the B6 strain. Interestingly, the observed differences qualitatively correlate with the strains' phenotypes: steatohepatitis 725 phenotypes were observed high, low, and unspecific for the AJ, B6, and PWD mouse strains, respectively [1].
We identified deregulated genes form the AJ under the DDC-supplemented diet vs PWD under DDC-supplemented diet and this is associated with NS vs S (see 730 materials and methods). For this comparison we identified 191 and 100 up-and downregulated genes, respectively (Table S1 ).
Up--and downregulated reactions in human and mouse
A reaction is marked as down regulated if genes associated to the reaction is down-735 regulated and if genes associated to the reaction is upregulated then the reaction is called as upregulated. If a reaction is associated to genes with mix-regulation (up-and down-regulation) then the reaction is not marked with up-or down-regulated.
Regulations of reactions are computed for the human expression data and mouse expression data (Fig. S2) . 740
Only for NS vs S, the number of down-regulated reactions was higher than the number of up-regulated reactions (Fig. S2 upper panel) , and a similar trend was observed for the number of up-and down-regulated genes (Fig. S1 upper panel and Tables S2-S3 ). The number of reactions up-and down-regulated was similar for NS vs N, but the number of down-regulated genes was higher than the number of 745 upregulated genes ( Fig. S1 and S2 upper panels). For S vs N, the number of downregulated reactions was higher than the number of up-regulated reactions; however, the numbers of up-and down-regulated genes for these conditions were similar ( Fig.   S1 and S2 upper panels). This observation indicates that the reaction regulation (RR)
is not always in agreement with the gene regulation, which results from the 750 dependency on the gene association set rather than a single gene.
For the AJ and B6 mouse strains, we found that the number of upregulated reactions was higher than the number of downregulated reactions, whereas for the PWD mouse strain the inverse was observed ( Fig. S2 lower panel) . For AJ and PWD, the gene 755 regulation followed the same trend for reaction regulation, whereas for B6 the numbers of up-and down-regulated genes and reactions remained comparable (Fig.   S1 ).
To represents as the human NS vs S we compared mice that have shown high nonalcoholic steatohepatitis (NS) phenotypes (AJ mice fed with the DDC-760 supplemented diet) to mice that have shown high steatosis (S) phenotypes (PWD mice fed with DDC supplemented diet). For the NS vs S in mice (see materials and methods; AJ DDC vs PWD DDC) we identified 459 and 191 up-and down-regulated reactions, respectively (Table S 2 
